Posted: October 3, 2011
Dr. Clifford Ian Chappel, and OVC ’50 graduate who went on to become a world-renowned medical researcher and entrepreneur, was honoured in 2003 as the OVC AA’s Distinguished Alumnus and the University of Guelph Alumni Association’s Alumnus of Honour.
After graduating from OVC, Chappel pursued graduate studies in the Department of Medicine at McGill University, earning a Ph.D. in Investigative Medicine.
Chappel’s distinguished career in medical research and business as the Director of Biological Research at Ayerst Laboratories Ltd. in Montreal, where he made a significant contribution to medical science through his discovery of acepromazine, a widely-used tranquilizer in veterinary medicine.
Later, he founded several research consulting companies, including Bio-Research Laboratories Ltd., Eco-Research Ltd. and CanTox Inc. He also formed Bio-Breeding Laboratories Ltd., a laboratory animal breeding facility in Ottawa.
Among his scientific accomplishments is the discovery of the BB rat, the first animal model for juvenile diabetes. These rats are now raised in colonies worldwide, allowing pathologists to examine progressive changes in the pancreas before the onset of diabetes.
A past-president of the Pharmacological Society of Canada and a founding member and first president of the Society of Toxicology of Canada, Chappel authored more than 60 scientific papers and reviews in investigative medicine, pharmacology and toxicology.
In 1987, Chappel established OVC’s annual Chappel Memorial Lecture in memory of his father. The lecture series allows University of Guelph faculty and students to learn from world-renowned biomedical scientists through an annual lecture and informal meetings.
“I grew up within a stone’s throw of OVC,” he says. “On my way home from school, along with my chums, we would stop by the vet school the large animal surgery at that time had large ground-floor windows where little boys could watch surgeries. That’s what convinced me of what I wanted to do.”